Wednesday, September 23, 2020

Converge Biotech Announces the Launch of Vergiflu (Favipiravir 200 mg) in India to Treat Mild to Moderate Covid-19

Must read

ShortsTV Partners with Asia’s Largest Content Fest, India Film Project

Mumbai, September 22, 2020. ShortsTV, the world's first and only 24/7 linear TV channel dedicated to short films, has...

Amazon Prime Video unveils the trailer of Telugu suspense thriller

Creating buzz with the unveiling of the film’s motion poster, Amazon Prime Video today released the trailer of Anushka Shetty and R...

Pad Up For An Innings Of Unrivalled Thrills As &flix Presents Flix Movie League

Mumbai, September 21, 2020. The much-awaited moment has arrived as one of the biggest sporting leagues finally takes centre...

बॉलीवुड एक्टर व प्रॉडयूसर राहुल रॉय की मौजूदगी में पुणे में आयोजित हुआ वीआ इंडिया अवार्ड्स सीजन 5 का ट्रॉफी लुक लॉन्च

Jaipur, September 21, 2020. जयपुर के फैशन एवं अवॉर्ड शो आर्गेनाइजर हरीश सोनी ने अपने अपकमिंग नेशनल लेवल अवॉर्ड...

Hyderabad, August 04, 2020.

Converge Biotech, a leading healthcare company based at Hyderabad, today announces the launch of generic Favipiravir tablet in India. It will be marketed under the brand name ‘VERGIFLU’ and is indicated for use in mild to moderate COVID-19 patients. Vergiflu is orally administered making it a convenient treatment option.

“We are delighted to announce the launch of Vergiflu for treatment of mild to moderate COVID-19 patients. At a time when cases are witnessing an alarming trend, our accelerated launch is aimed towards offering patients in India a much needed and timely therapy option. This strengthens our portfolio and keeps our commitment of bringing affordable therapy, accessible to patients,” said Managing Director of Converge Biotech Pvt Ltd, Arun Kumar Bijjala.

Favipiravir is an off patent; broad spectrum oral anti-viral drug backed by strong clinical evidence and has been shown to hasten clinical recovery in COVID -19 patients with mild to moderate symptoms. The drug is already approved for novel or re-emerging pandemic influenza virus infection in Japan since 2014, where high recovery rates have been reported with both 7 and 14 days of therapy in both mild and moderate patients. The drug has shorter viral clearance and faster recovery rate and is reported to have a wide therapeutic safety margin for COVID-19 dose.

The mechanism of action of Favipiravir is novel compared to existing influenza antivirals that primarily prevent entry and exit of the virus from cells. The drug has high affinity to RNA virus specific RNA polymerase and gets converted into an active phosphoribosylated form (favipiravir-RTP) in cells thereby inhibiting RNA polymerase activity.

The product is available from today in all major hospitals across the country. It will be sold only on prescription and the company will make sure that the drug is available to the patients.

Converge Biotech also has Prabinex HD (Injection vitamins c 1.5 g), Doxiverge (Inj Doxycycline 100 mg) and Oxihalt (Inj Glutathione 600mg) for hospitalised patients along with immunity boosters, Prabinex 500 mg (Tab Vitamin C 500mg) and Prabinex Z (Tab Vitamin C 500mg with Zinc 20mg); Divify (Vitamin D3 strips) and Tancyvit (Multivitamin).

More articles

Latest article

Prime Minister to interact with fitness enthusiasts from across the country

New Delhi, September 23, 2020. In a unique initiative, Prime Minister Shri. Narendra Modi will interact with fitness influencers...

More than 11 Lakh Indians Returned to India Under Vande Bharat Mission

New Delhi, September 23, 2020. Vande Bharat Mission consists of special repatriation flights operated by Indian carriers and chartered...

Sports Ministry to establish Khelo India State Centres of Excellence (KISCE) in Meghalaya and 5 more states

New Delhi, September 23, 2020. The Sports Ministry is set to establish the Khelo India Centre of Excellence (KISCE)...

Government has launched YuWaah – a multi-stakeholder platform to make young people career ready

New Delhi, September 23, 2020. Ministry of Youth Affairs & Sports and United Nations Children Fund (UNICEF) have signed...

Unbox your Pitaara of snacking delights for the festive season

Jaipur, September, 2020. Food and snacking is an inseparable part of our lives; more so when festivals are round...
Live Updates COVID-19 CASES